| 1 |
APOE‐associated disease risk and sex‐specific effects in Egyptian Alzheimer's disease: an exploratory study |
2026 |
| 2 |
Assessment of serum FAM19A5 level in patients with Neuromyelitis Optica spectrum disorder |
2026 |
| 3 |
Peripheral auditory function in Parkinson’s disease: findings from a pilot case-control study |
2026 |
| 4 |
Physical disability, cognition, and depression as determinants of quality of life in multiple sclerosis: a cross-sectional study |
2026 |
| 5 |
Tracking the invisible: Impact of disease-modifying therapies on serum neurofilament light chain and clinical outcomes in treatment-naïve multiple sclerosis |
2026 |
| 6 |
A Prospective Study Of The Impact Of An Emotional Intelligence Program On Opioid Relapse And Its Determinants In Upper Egyptر |
2025 |
| 7 |
APOE genetic variability in an Egyptian cohort of PD |
2025 |
| 8 |
Biallelic variation in the choline and ethanolamine transporter FLVCR1 underlies a severe developmental disorder spectrum |
2025 |
| 9 |
Frequency and risk factors of sleep problems in Egyptian patients with multiple sclerosis |
2025 |
| 10 |
Frequency, Risk Factors, Sex Differences, and Predictors of Post-Stroke Depression: A Multicenter Upper Egypt Study |
2025 |
Do you have any questions? 
